Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

Reumatología Clínica - Tập 16 - Trang 345-352 - 2020
Francisco J. Blanco1, Esteban Rubio-Romero2, Raimon Sanmartí3, César Díaz-Torné4, Pablo Talavera5, Jochen Dunkel6, Esperanza Naredo7
1INIBIC-Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
2Hospital Universitario Virgen del Rocio, Sevilla, Spain
3Hospital Clínic de Barcelona, Barcelona, Spain
4Hospital de la Santa Cruz y San Pablo, Barcelona, Spain
5UCB Pharma, Madrid, Spain
6UCB Pharma, Monheim, Germany
7Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz, Madrid, Spain

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Reumatología Clínica

Tập 16

345-352

Thông tin tác giả